Apyx Medical Corp (APYX) — insider trading
Health Care · Nasdaq
Apyx Medical Corp (APYX) has 18 reported SEC Form 4 insider transactions in our data (latest 2026-06-30).
Recent Form 4 transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | Waldman Lawrence | Director | Option exercise / conversion (derivative) | 12,000 | $0.00 | $0 | Form 4 |
| 2026-06-30 | Waldman Lawrence | Director | Shares withheld for taxes / exercise cost | 5,024 | $4.49 | $22.6K | Form 4 |
| 2026-06-30 | Waldman Lawrence | Director | Option exercise / conversion | 12,000 | $1.88 | $22.6K | Form 4 |
| 2026-06-15 | Roman Shawn David | Officer (Chief Operating Officer) | Option exercise / conversion (derivative) | 15,000 | $0.00 | $0 | Form 4 |
| 2026-06-15 | Roman Shawn David | Officer (Chief Operating Officer) | Shares withheld for taxes / exercise cost | 10,533 | $4.60 | $48.5K | Form 4 |
| 2026-06-15 | Roman Shawn David | Officer (Chief Operating Officer) | Option exercise / conversion | 15,000 | $3.23 | $48.5K | Form 4 |
| 2026-06-11 | CITRONOWICZ MOSHE | Officer (Sr. V.P. of Operations) | Grant / award / vesting (derivative) | 63,392 | $0.00 | $0 | Form 4 |
| 2026-06-11 | HILL MATTHEW C | Officer (Chief Financial Officer) | Grant / award / vesting (derivative) | 132,066 | $0.00 | $0 | Form 4 |
| 2026-06-11 | Waldman Lawrence | Director | Grant / award / vesting (derivative) | 50,000 | $0.00 | $0 | Form 4 |
| 2026-06-11 | Baylor-Henry Minnie | Director | Grant / award / vesting (derivative) | 50,000 | $0.00 | $0 | Form 4 |
| 2026-06-11 | Roman Shawn David | Officer (Chief Operating Officer) | Grant / award / vesting (derivative) | 88,044 | $0.00 | $0 | Form 4 |
| 2026-06-11 | Goodwin Charles D. II | Director, Officer (Chief Executive Officer) | Grant / award / vesting (derivative) | 213,948 | $0.00 | $0 | Form 4 |
| 2026-06-11 | Vizirgianakis Stavros G. | Director | Grant / award / vesting | 450,000 | $0.00 | $0 | Form 4 |
| 2026-06-11 | Levine Wendy Lauren | Director | Grant / award / vesting (derivative) | 50,000 | $0.00 | $0 | Form 4 |
| 2026-03-15 | CITRONOWICZ MOSHE | Officer (Senior Vice President) | Option exercise / conversion (derivative) | 37,000 | $0.00 | $0 | Form 4 |
| 2026-03-15 | CITRONOWICZ MOSHE | Officer (Senior Vice President) | Option exercise / conversion | 37,000 | $1.80 | $66.6K | Form 4 |
| 2026-01-27 | Roman Shawn David | Officer (Chief Operating Officer) | Option exercise / conversion (derivative) | 12,000 | $0.00 | $0 | Form 4 |
| 2026-01-27 | Roman Shawn David | Officer (Chief Operating Officer) | Option exercise / conversion | 12,000 | $1.80 | $21.6K | Form 4 |
Ask the chat about APYX's insider activity →
Transaction types are the SEC Form 4 codes: open-market purchases (P) and sales (S) are the only rows that reflect open-market conviction. Awards/vesting (A), option exercises (M/X/C), shares withheld for taxes (F) and gifts (G) are compensation or mechanical, not buying or selling on the open market. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan); open-market buying is not a recommendation to buy. Informational only — not financial advice.
Source: SEC EDGAR Form 3/4/5. See the full company profile: Apyx Medical Corp (APYX).
Last updated 2026-06-30 (most recent filing date).
Informational only — NOT financial advice. Insider filings are sourced from SEC EDGAR and shown with their reported dates.